BlackRock Inc. - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 29 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q1 2020$0
-100.0%
1,9270.0%0.00%
Q4 2019$1,0000.0%1,9270.0%0.00%
Q3 2019$1,000
-87.5%
1,9270.0%0.00%
Q2 2019$8,000
-88.1%
1,927
-78.3%
0.00%
Q4 2018$67,0008,8680.00%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q4 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 809,804$4,140,0000.60%
SABBY MANAGEMENT, LLC 514,878$2,652,0000.14%
Migdal Insurance & Financial Holdings Ltd. 497,200$2,542,0000.06%
Renaissance Technologies 12,944$66,0000.00%
DEUTSCHE BANK AG\ 12,724$65,0000.00%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders